Sep 16, 2024 / 02:30PM GMT
Operator
Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies first quarter fiscal year 2025 earnings call. We appreciate your time and interest in our company. Today's call will be led by our CEO, Dr. Jennifer bath, and our CFO, Kristin Taylor. They will provide a review of our financial performance, strategic initiatives and key operational highlights for the quarter.
Please note that a copy of today's presentation, along with our financial statements, will be available on our company website for your reference. We encourage you to review these materials to gain a deeper understanding of our performance and strategic direction. Once again, thank you for joining us today, and we look forward to sharing our progress and discussing our future plans with you.
Before we proceed, I would like to remind everyone that today's discussion will contain forward looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from those anticipated due to
Q1 2025 Immunoprecise Antibodies Ltd Earnings Call Transcript
3 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers